Do you want to present a clinical case at the Bolivia Sessions 2019? Send your case (spanish form) Terms and conditions
SOLACI-SBHCI 2019 Congress | Sponsored Activities by the Industry
The most important companies in the medical industry will present unforgettable scientific sessions with the participation of the most prestigious interventional cardiologists in the world. Access the scientific program Here Thursday 01/08/2019 ABBOTT Satellite Symposium 01/08 | Paulista Room | 12:15 – 02:00pm EDWARDS Mini Arena 01/08 | Sala Mini Arena | 02:00 – 03:30pm<a href="https://solaci.org/en/2019/07/16/solaci-sbhci-2019-congress-sponsored-activities-by-the-industry/" title="Read more" >...</a>
II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease
The II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease will take place on July 31st, 2019 at the Syrian-Lebanese Hospital in São Paulo. This event seeks to provide a better understanding of indications and clinical and interventional strategies for complex heart conditions, such as left main coronary<a href="https://solaci.org/en/2019/07/15/ii-international-symposium-on-innovations-in-the-treatment-of-coronary-artery-disease-and-structural-heart-disease/" title="Read more" >...</a>
DES with Bioresorbable Polymer vs. Bare Metal Stents in Primary PCI
Long after myocardial revascularization guidelines had established no medical reason justifies the use of bare metal stents (BMS), along comes this study to refresh the old trials comparing drug eluting vs bare metal stents in the context of primary PCI. The problem for many countries is that primary PCI obviously occurs in the context of<a href="https://solaci.org/en/2019/07/15/des-with-bioresorbable-polymer-vs-bare-metal-stents-in-primary-pci/" title="Read more" >...</a>
5-Year Experience of Appendage Closure: More Evidence that Does Not Translate into Clinical Practice
The use of percutaneous left appendage closure increased 3.6-fold from 2011 to 2015, but this volume increase did not entail a significant uptrend of in-hospital events in this “real-world” population in Germany. However, can Germany be considered a real-world setting for Latin America? This question is warranted by the fact that there is no apparent<a href="https://solaci.org/en/2019/07/10/5-year-experience-of-appendage-closure-more-evidence-that-does-not-translate-into-clinical-practice/" title="Read more" >...</a>
New ProEducar’s 113 Newsletter
The new ProEducar Educational Newsletter is out for all fellows, interventional trainees, and specialists in hemodynamics seeking to be up to date in their professional practice. This is a special issue on chronic total occlusion (CTO), one of the main current challenges for interventional cardiologists. This comprehensive, extensive work directed by Dr. Gustavo Pedernera includes<a href="https://solaci.org/en/2019/07/02/new-proeducars-113-newsletter/" title="Read more" >...</a>
Prosthetic Valve Endocarditis and TAVR: though Rare, Devastating
On the bright side, the incidence of prosthetic valve endocarditis (PVE) post TAVR is not higher than post SAVR, according to this study recently presented at EuroPCR 2019, held in Paris. There is plenty of evidence describing PVE incidence, prognosis, risk factors, etc. after surgical valve replacement surgery (SAVR). However, we know little about the<a href="https://solaci.org/en/2019/06/23/prosthetic-valve-endocarditis-and-tavr-though-rare-devastating/" title="Read more" >...</a>
The Most Read Articles of may in Interventional Cardiology
1- Surprising EXCEL Outcomes in Diabetics with Main Left Stenosis This study especially designed to compare PCI vs. CABG in patients with left main coronary artery disease and low to intermediate Syntax score showed that 30-day and 3 -year outcomes of PCI with everolimus eluting stents vs CABG were consistent both in diabetic and non-diabetic<a href="https://solaci.org/en/2019/06/06/the-most-read-articles-of-may-in-interventional-cardiology/" title="Read more" >...</a>
Grupo MIL Alongside Women as One in Paris
SOLACI’s Interventional Women in Latin American Group (Grupo de Mujeres Intervencionistas en Latinoamérica, Grupo MIL), led by its Director, Carla Agatiello, will participate in a Think Tank organized by Women as One, next Saturday, May 25th, at Westin Paris Vendôme Hotel in France. The aim of this meeting is to foster and facilitate the inclusion<a href="https://solaci.org/en/2019/05/24/grupo-mil-alongside-women-as-one-in-paris/" title="Read more" >...</a>
New Percutaneous Devices to Prevent Embolism in Atrial Fibrillation
Patients with atrial fibrillation (AF) unsuitable for anticoagulation because of bleeding risk, require other strategies to prevent stroke. For some years, there have been in the market (limited to some places; not as part of the regular agenda of cardiologists and hematologists) devices to occlude the atrium that have been proved safe and effective. These<a href="https://solaci.org/en/2019/05/19/new-percutaneous-devices-to-prevent-embolism-in-atrial-fibrillation/" title="Read more" >...</a>